H.G. Bonacorso et al. / Journal of Fluorine Chemistry 142 (2012) 90–95
95
(2C, Ph), 112.7 (C4a), 110.3 (C8), 105.9 (C6), 93.7 (q, J = 33 Hz, C2),
55.3, 55.1 (2C, OCH3), 54.2 (C3), 41.1 (CH3), 33.2 (C4).
GC–MS (EI, 70 eV) m/z (%): 396 (M+, 12), 353 (15) 243 (45), 121
(100).
112.9 (C4a), 109.5 (C8), 105.9 (C6), 93.5 (q, J = 33 Hz, C2), 69.5
(OCH2), 58.7 (C3), 39.1 (CH3), 29.6 (C4), 21.4 (CH2), 10.0 (CH3).
GC–MS (EI, 70 eV) m/z (%): 394 (M+, 19), 333 (100), 291 (62),
207 (69), 91 (50), 69 (38).
Anal. calcd. for C20H19F3O5 (396.35): C, 60.61; H, 4.83%. Found:
C, 60.80; H, 4.98%.
Anal. calcd. for C21H21F3O4 (394.13): C, 63.95; H, 5.37%. Found:
C, 64.03%; H, 5.41%.
Acknowledgments
4.2.10. 3-Benzoyl-2-hydroxy-5-methoxy-4-(4-methoxyphenyl)-2-
(trifluoromethyl)chromane (2h): white solid, mp 158–160 8C
1H NMR (CDCl3):
d = 7.49–7.43 (M, 4H, Ph), 7.30 7.27
The authors are grateful for the financial support from Conselho
´
´
Nacional de Desenvolvimento Cientıfico e Tecnologico – CNPq
(Proj. #s 470.788/2010-0 Universal and 303.013/2011-7). Fellow-
ships from CAPES and CNPq are also acknowledged.
(m, 2H, Ph), 7.23–7.17 (m, 1H, H7), 6.89 (d, J = 8 Hz, 2H, Ph),
6.74 (d, J = 8 Hz, 1H, H6), 6.60 (d, J = 8 Hz, 2H, Ph), 6.50 (d, J = 8 Hz,
1H, H8), 4.42 (d, J = 11 Hz, 1H, H3), 4.30 (d, J = 11 Hz, 1H, H4), 3.67,
3.37 (s, 6H, OCH3).
13C NMR (CDCl3):
d = 204.1 (C55O), 158.1 (C5), 157.6 (Ph), 150.7
References
(C8a), 136.2, 134.9, 134.2 128.6, 128.5, 128.4 (Ph), 128.0 (C7), 122.3
(q, J = 286, CF3), 113.7 (2C, Ph), 113.3 (C4a), 110.4 (C8), 105.9 (C6),
94.4 (q, J = 33 Hz, C2), 55.3, 55.1 (2C, OCH3), 48.9 (C3), 42.01 (C4).
GC–MS (EI, 70 eV) m/z (%): 458 (M+, 5), 353 (9), 105 (100),
77 (32).
[1] (a) M.J. Mphahlele, Molecules 14 (2009) 5308;
(b) H. Togo, S. Iida, Synlett 14 (2006) 2159;
(c) A. Banerjee, W. Vera, H. Mora, M. Laya, L. Bedoya, E.V. Cabrera, Journal of
Scientific and Industrial Research 65 (2006) 299.
[2] Y. Tamura, Y. Yoshimoto, Chemistry and Industry (1980) 888.
[3] A.S. Kotnis, Tetrahedron Letters 31 (1990) 481.
Anal. calcd. for C25H21F3O5 (458.13): C, 65.50; H, 4.62%. Found:
C, 65.78; H, 4.94%.
[4] S.G. Hegde, A.M. Kassim, A.I. Kennedy, Tetrahedron 57 (2001) 1689.
[5] (a) J.S. Yadav, B.V.S. Reddy, G. Sabitha, G.S.K. Reddy, Synthesis (2000) 1532;
(b) M.J. Mphahlele, F.K. Mogamisi, M. Tsanwani, S.M. Hlatshawayo, R.M. Mampa,
Journal of Chemical Research (1999) 706;
4.2.11. 3-(Furan-2-oyl)-2-hydroxy-5-methoxy-4-(4-
methoxyphenyl)-phenyl-2-(trifluoromethyl)chromane (2i): white
solid, mp 144–146 8C
(c) J.M. Kim, K.Y. Lee, J.N. Kim, Bulletin of the Korean Chemical Society 24
(2003) 1057;
(d) M.J. Mphahlele, A. Pienaar, T.A. Modro, Journal of the Chemical Society, Perkin
Transactions 2 (1996) 1455;
(e) P.T. Parvatkar, P.S. Parameswaran, S.G. Tilve, Chemistry- A European Journal
18 (2012) 5460.
1H NMR (CDCl3):
d = 7.65 (d,d, J = 1 Hz, 1H, Fur), 7.19 (t, J = 8 Hz,
1H, H7), 7.07 (d,d, J = 1 Hz, 1H, Fur), 6.92–6.88 (m, 3H, Fur, Ph), 6.74
(d, J = 8 Hz, 1H, H6), 6.61 (d J = 8 Hz, 2H, Ph), 6.49 (d, J = 8 Hz, 1H,
H8), 4.40 (d, J = 11 Hz, 1H, H3), 4.02 (d, J = 11 Hz, 1H, H4), 3.68, 3.37
(s, 6H, OCH3).
[6] (a) R.D. Chambers, Fluorine in Organic Chemistry, Blackwell, Oxford, 2004;
(b) P. Kirsh, Modern Fluoroorganic Chemistry, Wiley-VCH, Weinheim, Germany,
2004;
(c) J.P. Begue´, D. Bonnet-Delpon, Bioorganic and Medicinal Chemistry of Fluorine,
Wiley, Hoboken, NJ, 2008;
(d) P. Maienfish, R.G. Hall, Chimia 58 (2004) 93;
13C NMR (CDCl3):
d = 189.8 (C55O), 158.0 (C5), 157.6 (Ph), 151.9
(Fur), 150.6 (C8a), 148.9 (Fur), 134.9, 128.8 (3C, Ph), 127.9 (C7),
122.3 (q, J = 286, CF3), 121.0 (fur), 113.6 (Fur), 113.0 (2C, Ph), 112.9
(C4a), 110.4 (C8), 105.9 (C6), 94.2 (q, J = 33 Hz, C2), 55.4, 55.1 (2C,
OCH3), 49.8 (C3), 41.3 (C4).
(e) Z.-P. Liu, Current Organic Chemistry 14 (2010) 888;
(f) K. Mikami, Y. Itoh, M. Yamanaka, Chemical Reviews 1 (2004) 104.
[7] (a) R. Filler, Y. Kobayashi (Eds.), Biomedicinal Aspects of Fluorine Chemistry,
Elsevier, Amsterdam, 1982;
(b) J.T. Welch, S. Eswarakrishnan, Fluorine in Bioorganic Chemistry, John Wiley
&Sons, New York, 1990;
(c) R. Filler, Y. Kobayashi, L.M. Yagupolski (Eds.), Organofluorine Compounds in
Medicinal Chemistry and Biomedical Applications, Elsevier, Amsterdam, 1993.
[8] R.E. Filler, Organic Chemistry in Medicinal Chemistry and Applications, Plenum
and Elsevier, Amsterdam, 1993.
GC–MS (EI, 70 eV) m/z (%): 448 (M+, 5), 241 (9), 121 (23), 95
(100).
Anal. calcd. for C23H19F3O6 (448.11): C, 61.61; H, 4.27%. Found:
C, 62.05; H, 4.40%.
[9] R. Ling, M. Yoshida, P.S. Mariano, Journal of Organic Chemistry 61 (1996) 4439.
[10] (a) M.A. McClinton, D.A. McClinton, Tetrahedron 48 (1992) 6555;
(b) P. Lin, J. Jiang, Tetrahedron 56 (2000) 3635.
4.2.12. 3-Acetyl-5-ethoxy-2-hydroxy-4-phenyl-2(-
trifluoromethyl)chromane (3a): yellow oil
[11] E.E. Schweizer, D. Meeder-Nycz, Heterocyclic Compounds: Chromenes, Ellis G.P.,
New York, 1977, pp. 11–139.
[12] (a) T. Harada, T. Hayashiya, I. Wada, N. Iwa-ake, A. Oku, Journal of the American
Chemical Society 109 (1987) 527;
(b) S. Inoue, H. Ikeda, S. Sato, K. Horie, T. Ota, O. Miyamoto, K. Sato, Journal of
Organic Chemistry 52 (1987) 5495.
[13] I.M. Chandler, C.R. McIntyre, T.J. Simpson, Journal of the Chemical Society, Perkin
Transactions 1 (1992) 2271.
1H NMR (CDCl3):
d = 7.25–7.20 (m, 4H, Ph), 7.11–7.05
(m, 2H, Ph, H7), 6.66 (d, J = 8 Hz, 1H, H6), 6.42 (d, J = 8 Hz, 1H,
H8), 4.25 (d, J = 11 Hz, 1H, H3), 3.84–3.69 m (m, 1H, CH2), 3.47
(d, J = 11 Hz, 1H, H4), 3.40–3.36 (m, 1H, CH2), 1.80 (s, 3H, CH3), 0.73
(t, J = 7 Hz, 3H, CH3).
13C NMR (CDCl3):
d = 212.9 (C55O), 156.8 (C5), 150.5 (C8a),
[14] (a) H. Haberlein, K.-P. Tschiersch, Biochemical Systematics and Ecology 26
(1998) 97;
143.0 128.8, 128.6 127.1 (6C, Ph), 126.6 (C7), 122.3 (q, J = 286, CF3),
111.7 (C4a), 109.9 (C8), 105.9 (C6), 93.5 (q, J = 33 Hz, C2), 63.5
(CH2), 54.0 (C3), 42.0 (C4), 33.0, 13.8 (CH3).
GC–MS (EI, 70 eV) m/z (%): 380 (M+, 14), 319 (100), 291 (20),
105 (14).
(b) H. Poerwono, S. Sasaki, Y. Hattori, K. Higashiyama, Bioorganic and Medicinal
Chemistry Letters 20 (2010) 2086.
[15] H.G. Bonacorso, J. Navarini, C.W. Wiethan, G.P. Bortolotto, G.R. Paim, S. Cavinatto,
M.A.P. Martins, N. Zanatta, M.S.B. Caro, Journal of Fluorine Chemistry 132
(2010) 160.
[16] J.M. Mphahlele, T.B. Moekwa, Organic & Biomolecular Chemistry 3 (2005) 2469.
[17] M. Rueping, E. Sugiono, E. Merino, Chemistry- A European Journal 14 (2008) 6329.
[18] Crystallographic data for the structure of 2h, reported in this paper have been
deposited with the Cambridge Crystallographic Data Centre and allocated the
deposition number CCDC 872165. Copies of the data can be obtained free of
charge, on application to CCDC 12 Union Road, Cambridge CB2 1EZ, UK (fax: +44
[19] Bruker, APEX2 (Version 2.1), COSMO (Version 1.56), BIS (Version 2.0.1.9), SAINT
(Version 7.3A) and SADABS (Version 2004/1) and XPREP9 (Version 2005/4),
Bruker AXS Inc., Madison, WI, USA, 2006.
Anal. calcd. for C20H19F3O4 (380.35): C, 63.15; H, 5.03%. Found:
C, 63.14; H, 5.09%.
4.2.13. 3-Acetyl-2-hydroxy-4-phenyl-5-propoxy-2-
(trifluoromethyl)chromane (4a): yellow oil
1H NMR (CDCl3):
d = 7.27–7.20 (m, 3H, Ph), 7.15 (t, J = 8 Hz, 1H,
H7), 7.08–7.06 (m, 2H, Ph), 6.67 (J = 8 Hz, 1H, H8), 6.43 (d, J = 8 Hz,
1H, H6), 4.26 (d, J = 11 Hz, 1H, H3), 3.65–3.60 (m, 1H, CH2), 3.46
(d, J = 11 Hz, 1H, H4), 3.40–3.35 (m, 1H, CH2), 1.79 (s, 3H, CH3), 1.13
(sex, J = 7 Hz, 2H, CH2), 0.60 (t, J = 7 Hz, 3H, CH3).
[20] G.M. Sheldrick, SHELXS-97, Program for Crystal Structure Solution, University of
Go¨ttingen, Germany, 1997.
[21] G.M. Sheldrick, SHELXL-97, Program for Crystal Structure Refinement, University
of Go¨ttingen, Germany, 1997.
[22] P. Coppens, L. Leiserowitz, D. Rabinovich, Acta Crystallographica 18 (1965) 1035.
[23] L.J. Farrugia, Journal of Applied Crystallography 30 (1997) 565.
13C NMR (CDCl3):
143.1, 128.4, 128.0, 127.0 (Ph), 126.1 (C7), 122.3 (q, J = 286, CF3),
d = 204.2 (C55O), 156.85 (C5), 150.5 (C8a),